Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Double antibiotic paste mixed with chitosan nanoparticles is an investigational dental medicament developed by Ain Shams University for use in Lesion Sterilization and Tissue Repair (LSTR) therapy. It is specifically designed for the treatment of non-vital primary molars exhibiting pulp necrosis and significant root resorption. The formulation combines two antibiotics (typically ciprofloxacin and metronidazole) with chitosan nanoparticles, which act as a bioactive delivery vehicle. This combination is intended to provide enhanced antimicrobial efficacy against endodontic pathogens and facilitate tissue healing by allowing for a more effective and sustained release of the active ingredients into the root canal system compared to traditional vehicles like propylene glycol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on double antibiotic paste mixed with chitosan nanoparticles.